DOI:
10.1055/s-00046370
Global Medical Genetics
LinksClose Window
References
Yang JC, Sequist LV, Geater SL. et al.
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6.
Lancet Oncol 2015;
16 (07) 830-838
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.